esketamine has been researched along with Cognitive Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, JG; Li, Y; Song, RX; Wang, JX; Wu, ZY; Zheng, WC | 1 |
| Li, Y; Liu, JZ; Lv, JM; Miao, HT; Shan, YD; Song, RX; Wang, LY; Wu, ZY; Zhang, DX; Zhang, LM; Zhang, W | 1 |
| Hashimoto, K | 1 |
| Cohen, D; Curiale, V; Jacquet, B; Laurent, I; Louchart De La Chapelle, S; Romani, S | 1 |
1 review(s) available for esketamine and Cognitive Dysfunction
| Article | Year |
|---|---|
Arketamine for cognitive impairment in psychiatric disorders.
Topics: Animals; Antidepressive Agents; Cognitive Dysfunction; Depressive Disorder, Major; Ketamine; Mice | 2023 |
3 other study(ies) available for esketamine and Cognitive Dysfunction
| Article | Year |
|---|---|
Esketamine alleviates postoperative cognitive decline via stimulator of interferon genes/ TANK-binding kinase 1 signaling pathway in aged rats.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cognitive Dysfunction; Hippocampus; Interferons; Ketamine; Lipopolysaccharides; Membrane Proteins; Postoperative Cognitive Complications; Postoperative Complications; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction | 2022 |
Subanesthetic dose of S-ketamine improved cognitive dysfunction via the inhibition of hippocampal astrocytosis in a mouse model of post-stroke chronic stress.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Gliosis; Hippocampus; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Stroke | 2023 |
Esketamine for resistant depression in older people with cognitive impairment: A case report.
Topics: Aged; Antidepressive Agents; Cognitive Dysfunction; Depression; Depressive Disorder, Treatment-Resistant; Humans; Ketamine | 2023 |